Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Little Green Pharma Ltd. ( (AU:LGP) ) has issued an update.
Little Green Pharma Ltd reported a 9.6% increase in revenue to $19.225 million for the half-year ending September 2025, with a significant reduction in net loss by 73.2% to $926,000. The company’s adjusted EBITDA improved to $2.637 million, indicating better operational efficiency despite a decrease in net operating cash inflow. These results reflect a positive trajectory for the company, potentially strengthening its position in the medicinal cannabis market.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd operates in the medicinal cannabis industry, focusing on the sale of medicinal cannabis products and the provision of distribution services.
Average Trading Volume: 200,916
Technical Sentiment Signal: Buy
Current Market Cap: A$39.73M
Learn more about LGP stock on TipRanks’ Stock Analysis page.